Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Pertuzumab
Latest prescription information about Pertuzumab. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
|
Generic Name : Pertuzumab
Therapeutic Classification : Monoclonal antibodies
ICD Code : Y43.4
Trade Name(s): International- Perjeta. Why it is prescribed (Indications) : This medication is a monoclonal antibody, prescribed for HER2-positive breast cancer (which is more aggressive) either alone or with other medications. It stops cancer cell growth. When it is not to be taken (Contraindications): None.
Dosage & When it is to be taken : IV- The recommended initial dose is 840 mg, followed every 3 weeks thereafter by a dose of 420 mg. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein. Warnings and Precautions : * Caution should be exercised in patients with liver or kidney impairment, during pregnancy and breastfeeding. * Patient may develop with increased risk of ventricular dysfunction; monitor heart function regularly while taking this medication. * It may cause harm to fetus when it is administered to pregnant women; consult with your healthcare provider before taking this medication. Side Effects : Most Common - Diarrhea, hair loss, decrease in white blood cells, stomach upset, fatigue, rash, damage to the nerves. General - Fatigue, weakness, swelling in the extremities, fever. Skin- Hair loss, nail disorder, itching, dry skin. Gastrointestinal - Nausea, vomiting, constipation, mouth ulcer. Blood - Anemia. Central Nervous System - Headache, change in taste, dizziness, and sleeplessness. Musculoskeletal - Muscle pain, joint pain. Infections - Upper respiratory tract infection, nose inflammation. Respiratory - Difficulty in breathing. Metabolic - Decreased appetite. Eye - Increased tears. * Avoid excess dosage. Storage Conditions : Store vials in a refrigerator at 2°C to 8°C. |
 Comment & Contribute
| ||
Browse the Drugs alphabetically
Reference
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- PubMed
- CIMS
- Indian Pharma Reference Guide 2012
Ask an Expert
